FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

17 letters match. Newest first.

  1. Confer With

    FDA told London-based Confer With that its Vivant True Tone skin-lightening serum is an unapproved drug sold without FDA approval.

    High risk
  2. ISIS.GOLD

    ISIS.GOLD sells TCA 100% and Whitening SA chemical peels as unapproved new drugs without FDA-approved applications.

    High risk
  3. Bi-Coastal Pharma International

    FDA warned Bi-Coastal Pharma International about adulterated drugs due to poor complaint handling, quality-unit oversight, batch release, and training.

    High risk
  4. Monarch PCM, LLC

    Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.

    High risk
  5. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  6. Elements Brands Inc.

    FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.

    High risk
  7. SkinPro

    SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.

    High risk
  8. Skin PS Brands

    FDA warns Skin PS Brands that Dark Spot Fix, a hydroquinone skin-lightening drug, is an unapproved and misbranded new drug.

    High risk
  9. Clinical Formula LLC

    FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.

    Medium
  10. Neoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.

    FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.

    Medium
  11. Dr. Thomas Balshi/Intilight

    FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.

    High risk
  12. Skin Authority, L.L.C.

    FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.

    High risk
  13. AMBI Enterprises LLC

    AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.

    High risk
  14. M & M Beauty and Wellness, LLC

    FDA says M & M Beauty and Wellness sells an unapproved, misbranded hydroquinone skin-lightening cream.

    High risk
  15. True Earth Health Products, LLC

    FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.

    High risk
  16. Generitech Corporation

    FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.

    High risk
  17. Sanitor Corporation

    Sanitor Corporation was cited for CGMP violations after hand sanitizer failed microbial testing and skin-bleaching drugs were sold without approval.

    High risk